 |
 |

Malignant Neoplasms Following Cardiac Transplantation
John G. Krikorian, MD;
Jeffrey L. Anderson, MD;
Charles P. Bieber, MD;
Israel Penn, MD;
Edward B. Stinson, MD
JAMA. 1978;240(7):639-643.
Abstract
Between Jan 6, 1968, and April 11, 1977, 124 patients underwent cardiac transplantation at Stanford University Medical Center, with a mean and median period of follow-up of 18.3 and 9.7 months, respectively. Malignant neoplasms developed in seven patients—three lymphoproliferative neoplasms, two skin cancers, one acute leukemia, and one colon carcinoma. Visceral tumors were often fatal and caused 11% of deaths after three months following transplantation. The incidence and spectrum of malignant neoplasms in this population are similar to those observed in recipients of renal homografts.
(JAMA 240:639-643, 1978)
Author Affiliations
From the Divisions of Oncology (Dr Krikorian) and Cardiology (Dr Anderson), and Department of Cardiovascular Surgery (Drs Bieber and Stinson), Stanford University School of Medicine, Stanford, Calif; and Department of Surgery (Dr Penn), University of Colorado Medical School, and Denver Veterans Administration Hospital (Dr Penn), Denver.
Footnotes
Reprint requests to Cardiology Division, Stanford University Medical Center, Stanford, CA 94305 (Dr Anderson).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Heart Transplantation
Bethea et al.
Card Surg Adult 2003;2:1427-1460.
FULL TEXT
Posttransplant primary CNS lymphoma
Phan et al.
Neuro Oncol Duke 2000;2:229-238.
ABSTRACT
Emerging treatments in multiple sclerosis: Azathioprine and Mof etil
Confavreux and Moreau
Mult Scler 1996;1:379-384.
ABSTRACT
Solid Tumors After Heart Transplantation: Lethality of Lung Cancer
Pham et al.
Ann. Thorac. Surg. 1995;60:1623-1626.
ABSTRACT
| FULL TEXT
De Novo Solid Malignancies After Cardiac Transplantation
Goldstein et al.
Ann. Thorac. Surg. 1995;60:1783-1789.
ABSTRACT
| FULL TEXT
Second Lymphoid Malignant Neoplasms Occurring in Patients Treated for Hodgkin's Disease
Armitage et al.
Arch Intern Med 1983;143:445-450.
ABSTRACT
|